Mechanistically, HSPD1 sustains tumor cell survival by suppressing pro-apoptotic signaling through the p53-survivin axis, positioning HSP60 as a therapeutically actionable node to overcome apoptotic resistance. Here, TP53 is linked to neoplasm.